TP53 and breast carcinoma: In contrast, in MCF7 breast cancer cells, the cell line’s molecular landscape likely supports the maintenance of genomic integrity upon activation of the p53-p21 cell cycle checkpoint and drives SSX2-expressing cancer cells toward senescence through the Mediator complex.198